Use of a biochip assaying 28 mutations in the KRAS, BRAF, TP53, and APC genes for detection of colorectal neoplasia

被引：1
|
作者：
Hughes, D. [1 ]
O'Morain, C. [1 ]
Lee, N. [1 ]
Kelley, L. [1 ]
McMurray, H. [2 ]
Latten, M. [2 ]
Ebert, M. [3 ]
机构：
[1] AMNCH Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[2] Randox Labs, DNA Diagnost, Crumlin, Ireland
[3] Tech Univ Munich, Munich, Germany
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70936-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：33 / 34
页数：3
相关论文
共 50 条
  • [41] An integral genomic/expression analysis reveals a cooperative role of APC and TP53 mutations in identifying cetuximab-sensitive colorectal cancer
    Yang, Mingli
    Schell, Michael J.
    Loboda, Andrey
    Nebozhyn, Michael V.
    Li, Jiannong
    Teer, Jamie K.
    Pledger, W. Jack
    Yeatman, Timothy J.
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Mutational Landscape of BRAF-Mutated Microsatellite-Stable Colorectal Cancer Shows High Prevalence of Concurrent TP53 Mutations
    Wu, Elizabeth Yiru
    Dong, Fei
    Lindeman, Neal I.
    Srivastava, Amitabh
    MODERN PATHOLOGY, 2017, 30 : 207A - 207A
  • [43] Mutational Landscape of BRAF-Mutated Microsatellite-Stable Colorectal Cancer Shows High Prevalence of Concurrent TP53 Mutations
    Wu, Elizabeth Yiru
    Dong, Fei
    Lindeman, Neal I.
    Srivastava, Amitabh
    LABORATORY INVESTIGATION, 2017, 97 : 207A - 207A
  • [44] Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
    Sclafani, Francesco
    Wilson, Sanna Hulkki
    Cunningham, David
    De Castro, David Gonzalez
    Kalaitzaki, Eleftheria
    Begum, Ruwaida
    Wotherspoon, Andrew
    Capdevila, Jaume
    Glimelius, Bengt
    Rosello, Susana
    Thomas, Janet
    Tait, Daina
    Brown, Gina
    Oates, Jacqui
    Chau, Ian
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (01) : 94 - 102
  • [45] The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer
    Alizadeh-Sedigh, Maryam
    Mahmoodzadeh, Habibollah
    Fazeli, Mohammad Sadegh
    Haddadi-Aghdam, Mohammad
    Teimoori-Toolabi, Ladan
    MOLECULAR AND CELLULAR PROBES, 2022, 63
  • [46] Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis
    Smits, R
    Kartheuser, A
    JagmohanChangur, S
    Leblanc, V
    Breukel, C
    deVries, A
    vanKranen, H
    vanKrieken, JH
    Williamson, S
    Edelmann, W
    Kucherlapati, R
    Kan, PM
    Fodde, R
    CARCINOGENESIS, 1997, 18 (02) : 321 - 327
  • [47] Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease
    Davy Carlos Mendes Rapozo
    Ana Braunstein Grinmann
    Ana Teresa Pugas Carvalho
    Heitor Siffert P. de Souza
    Sheila Coelho Soares-Lima
    Tatiana de Almeida Simão
    Daurita de Paiva
    Flávio Abby
    Rodolpho Mattos Albano
    Luiz Felipe Ribeiro Pinto
    International Journal of Colorectal Disease, 2009, 24 : 1141 - 1148
  • [48] Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease
    Mendes Rapozo, Davy Carlos
    Grinmann, Ana Braunstein
    Pugas Carvalho, Ana Teresa
    de Souza, Heitor Siffert P.
    Soares-Lima, Sheila Coelho
    Simao, Tatiana de Almeida
    de Paiva, Daurita
    Abby, Flavio
    Albano, Rodolpho Mattos
    Ribeiro Pinto, Luiz Felipe
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (10) : 1141 - 1148
  • [49] Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
    Loes, Inger Marie
    Immervoll, Heike
    Sorbye, Halfdan
    Angelsen, Jon-Helge
    Horn, Arild
    Knappskog, Stian
    Lonning, Per Eystein
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (03) : 647 - 656
  • [50] THE ROLE OF CELL-FREE CIRCULATING TUMOR DNA (CTDNA) DEFINED BY KRAS AND TP53 MUTATIONS IN THE ASSESSMENT OF COLORECTAL CANCER RECURRENCE: A META-ANALYSIS.
    Siddiqui, M.
    Bhoday, J.
    Chand, M.
    Freudian, M.
    Tekkis, P.
    Lim, E.
    Abulafi, A.
    Brown, G.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E219 - E220
12345